TP53 and hepatocellular carcinoma: The current evidence points to a pivotal role of p53 in liver disease, whereby a controlled degree of activation seems beneficial in many stages of the pathogenesis, while complete loss of function, but also hyper-activation appear to be detrimental and could promote liver disease and HCC (Figure 2).